Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.44
-0.12 (-1.83%)
Mar 9, 2026, 2:06 PM EDT - Market open
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.68 billion as of March 9, 2026. Its market cap has decreased by -58.51% in one year.
Market Cap
1.68B
Enterprise Value
9.91B
1-Year Change
-58.51%
Ranking
Category
Stock Price
$6.44
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.68B, a decrease of -80.08%. That is a compound annual growth rate of -28.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.71B | -8.39% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 171.00B |
| Pfizer | 153.81B |
| Bristol-Myers Squibb Company | 122.78B |
| GSK plc | 109.35B |
| Sanofi | 106.99B |
| Biogen | 27.13B |
| Grifols | 7.16B |
| Amarin Corporation | 292.50M |